|
|
arginine metabolic process
|
GO:0006525 |
3 |
0.990
|
|
|
|
glutamine family amino acid catabolic process
|
GO:0009065 |
8 |
0.977
|
|
|
|
regulation of cyclase activity
|
GO:0031279 |
19 |
0.972
|
|
|
|
cellular response to camp
|
GO:0071320 |
21 |
0.946
|
|
|
|
response to increased oxygen levels
|
GO:0036296 |
4 |
0.942
|
|
|
|
cellular amino acid catabolic process
|
GO:0009063 |
31 |
0.903
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
79 |
0.897
|
|
|
|
positive regulation of guanylate cyclase activity
|
GO:0031284 |
1 |
0.889
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
3 |
0.888
|
|
|
|
glutamine family amino acid metabolic process
|
GO:0009064 |
17 |
0.887
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
82 |
0.881
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
61 |
0.866
|
|
|
|
positive regulation of cgmp biosynthetic process
|
GO:0030828 |
3 |
0.863
|
|
|
|
vasodilation
|
GO:0042311 |
4 |
0.854
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
38 |
0.831
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
12 |
0.829
|
|
|
|
regulation of system process
|
GO:0044057 |
101 |
0.822
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
1 |
0.804
|
|
|
|
regulation of guanylate cyclase activity
|
GO:0031282 |
2 |
0.802
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
50 |
0.789
|
|
|
|
positive regulation of cyclic nucleotide biosynthetic process
|
GO:0030804 |
38 |
0.776
|
|
|
|
modification of morphology or physiology of other organism
|
GO:0035821 |
43 |
0.754
|
|
|
|
endocrine process
|
GO:0050886 |
25 |
0.731
|
|
|
|
positive regulation of purine nucleotide biosynthetic process
|
GO:1900373 |
38 |
0.727
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
125 |
0.725
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
35 |
0.723
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
18 |
0.719
|
|
|
|
positive regulation of cgmp metabolic process
|
GO:0030825 |
5 |
0.716
|
|
|
|
response to activity
|
GO:0014823 |
0 |
0.705
|
|
|
|
regulation of smooth muscle cell proliferation
|
GO:0048660 |
28 |
0.690
|
|
|
|
positive regulation of vasodilation
|
GO:0045909 |
4 |
0.688
|
|
|
|
alpha amino acid catabolic process
|
GO:1901606 |
26 |
0.686
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
12 |
0.676
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
60 |
0.671
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
50 |
0.670
|
|
|
|
heart contraction
|
GO:0060047 |
62 |
0.657
|
|
|
|
regulation of killing of cells of other organism
|
GO:0051709 |
4 |
0.657
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
50 |
0.646
|
|
|
|
endothelial cell migration
|
GO:0043542 |
86 |
0.644
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
63 |
0.643
|
|
|
|
positive regulation of lyase activity
|
GO:0051349 |
16 |
0.636
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
88 |
0.631
|
|
|
|
cellular response to metal ion
|
GO:0071248 |
43 |
0.626
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
109 |
0.622
|
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
71 |
0.596
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
92 |
0.592
|
|
|
|
response to hyperoxia
|
GO:0055093 |
4 |
0.592
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.587
|
|
|
|
negative regulation of axon extension
|
GO:0030517 |
2 |
0.585
|
|
|
|
negative regulation of smooth muscle cell proliferation
|
GO:0048662 |
14 |
0.562
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
94 |
0.551
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.551
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.549
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
84 |
0.533
|
|
|
|
bud outgrowth involved in lung branching
|
GO:0060447 |
1 |
0.530
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
163 |
0.527
|
|
|
|
regulation of insulin secretion
|
GO:0050796 |
33 |
0.525
|
|
|
|
positive regulation of cyclase activity
|
GO:0031281 |
13 |
0.513
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
81 |
0.499
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
71 |
0.495
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
4 |
0.494
|
|
|
|
regulation of vasodilation
|
GO:0042312 |
4 |
0.491
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.484
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.463
|
|
|
|
postnatal olfactory bulb interneuron migration
|
GO:0021827 |
2 |
0.463
|
|
|
|
positive regulation of cyclic nucleotide metabolic process
|
GO:0030801 |
49 |
0.454
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.452
|
|
|
|
cellular response to heat
|
GO:0034605 |
14 |
0.440
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
70 |
0.440
|
|
|
|
regulation of heart rate
|
GO:0002027 |
38 |
0.436
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.425
|
|
|
|
response to metal ion
|
GO:0010038 |
84 |
0.424
|
|
|
|
bone development
|
GO:0060348 |
26 |
0.418
|
|
|
|
response to camp
|
GO:0051591 |
25 |
0.409
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.396
|
|
|
|
blood circulation
|
GO:0008015 |
113 |
0.392
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.392
|
|
|
|
positive regulation of cardiac muscle cell proliferation
|
GO:0060045 |
2 |
0.382
|
|
|
|
arginine catabolic process
|
GO:0006527 |
3 |
0.382
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.372
|
|
|
|
positive regulation of killing of cells of other organism
|
GO:0051712 |
4 |
0.370
|
|
|
|
peptide secretion
|
GO:0002790 |
51 |
0.365
|
|
|
|
response to growth factor
|
GO:0070848 |
205 |
0.361
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
82 |
0.361
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
72 |
0.358
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
30 |
0.345
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
94 |
0.344
|
|
|
|
nitric oxide biosynthetic process
|
GO:0006809 |
20 |
0.342
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.339
|
|
|
|
response to estradiol
|
GO:0032355 |
23 |
0.338
|
|
|
|
response to axon injury
|
GO:0048678 |
1 |
0.333
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.332
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.327
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.326
|
|
|
|
heart process
|
GO:0003015 |
62 |
0.321
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
57 |
0.320
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
59 |
0.315
|
|
|
|
nitric oxide metabolic process
|
GO:0046209 |
22 |
0.296
|
|
|
|
defense response to bacterium
|
GO:0042742 |
63 |
0.287
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
45 |
0.282
|
|
|
|
regulation of tube size
|
GO:0035150 |
18 |
0.280
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.279
|
|
|
|
cgmp metabolic process
|
GO:0046068 |
19 |
0.275
|
|
|
|
regulation of systemic arterial blood pressure by endothelin
|
GO:0003100 |
4 |
0.273
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
19 |
0.269
|
|
|
|
hormone secretion
|
GO:0046879 |
65 |
0.267
|
|
|
|
epithelial cell migration
|
GO:0010631 |
119 |
0.266
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
50 |
0.263
|
|
|
|
cellular response to mechanical stimulus
|
GO:0071260 |
39 |
0.245
|
|
|
|
defense response to other organism
|
GO:0098542 |
129 |
0.241
|
|
|
|
tissue migration
|
GO:0090130 |
119 |
0.240
|
|
|
|
epithelium migration
|
GO:0090132 |
119 |
0.239
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
157 |
0.238
|
|
|
|
salivary gland morphogenesis
|
GO:0007435 |
4 |
0.236
|
|
|
|
positive regulation of blood circulation
|
GO:1903524 |
12 |
0.234
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
3 |
0.232
|
|
|
|
cellular response to nitrogen compound
|
GO:1901699 |
144 |
0.230
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
41 |
0.230
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.230
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.228
|
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
76 |
0.227
|
|
|
|
regulation of cell killing
|
GO:0031341 |
22 |
0.226
|
|
|
|
peptide transport
|
GO:0015833 |
74 |
0.222
|
|
|
|
response to magnesium ion
|
GO:0032026 |
3 |
0.220
|
|
|
|
circulatory system process
|
GO:0003013 |
113 |
0.218
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.213
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
135 |
0.211
|
|
|
|
smooth muscle cell proliferation
|
GO:0048659 |
28 |
0.210
|
|
|
|
response to corticosteroid
|
GO:0031960 |
15 |
0.208
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
29 |
0.208
|
|
|
|
positive regulation of cell killing
|
GO:0031343 |
19 |
0.208
|
|
|
|
cell killing
|
GO:0001906 |
34 |
0.206
|
|
|
|
positive regulation of cell fate specification
|
GO:0042660 |
2 |
0.205
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
82 |
0.205
|
|
|
|
positive regulation of urothelial cell proliferation
|
GO:0050677 |
1 |
0.203
|
|
|
|
response to acid chemical
|
GO:0001101 |
66 |
0.201
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.189
|
|
|
|
response to organophosphorus
|
GO:0046683 |
41 |
0.186
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.183
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.182
|
|
|
|
response to amino acid
|
GO:0043200 |
14 |
0.181
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.179
|
|
|
|
regulation of cgmp metabolic process
|
GO:0030823 |
9 |
0.174
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
191 |
0.173
|
|
|
|
specification of organ identity
|
GO:0010092 |
3 |
0.169
|
|
|
|
response to ketone
|
GO:1901654 |
19 |
0.164
|
|
|
|
outer ear morphogenesis
|
GO:0042473 |
2 |
0.161
|
|
|
|
disruption of cells of other organism
|
GO:0044364 |
7 |
0.161
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.159
|
|
|
|
hormone transport
|
GO:0009914 |
68 |
0.155
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.151
|
|
|
|
cell cell signaling
|
GO:0007267 |
155 |
0.150
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.148
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.147
|
|
|
|
amide transport
|
GO:0042886 |
76 |
0.147
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.145
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.144
|
|
|
|
response to drug
|
GO:0042493 |
81 |
0.144
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.143
|
|
|
|
regulation of cgmp biosynthetic process
|
GO:0030826 |
4 |
0.142
|
|
|
|
regulation of saliva secretion
|
GO:0046877 |
2 |
0.142
|
|
|
|
response to purine containing compound
|
GO:0014074 |
40 |
0.141
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.139
|
|
|
|
organ induction
|
GO:0001759 |
4 |
0.138
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
62 |
0.137
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.136
|
|
|
|
mesodermal cell fate specification
|
GO:0007501 |
2 |
0.132
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.132
|
|
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.130
|
|
|
|
mammary gland formation
|
GO:0060592 |
1 |
0.128
|
|
|
|
response to steroid hormone
|
GO:0048545 |
80 |
0.127
|
|
|
|
response to monosaccharide
|
GO:0034284 |
20 |
0.125
|
|
|
|
response to fluid shear stress
|
GO:0034405 |
14 |
0.125
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.125
|
|
|
|
synaptic vesicle endocytosis
|
GO:0048488 |
2 |
0.124
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
42 |
0.122
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.121
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.121
|
|
|
|
regulation of organ formation
|
GO:0003156 |
4 |
0.120
|
|
|
|
insulin secretion
|
GO:0030073 |
39 |
0.120
|
|
|
|
regulation of mesoderm development
|
GO:2000380 |
4 |
0.119
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.119
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.114
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.114
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.110
|
|
|
|
lung associated mesenchyme development
|
GO:0060484 |
1 |
0.109
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.109
|
|
|
|
response to estrogen
|
GO:0043627 |
47 |
0.107
|
|
|
|
cranial nerve morphogenesis
|
GO:0021602 |
1 |
0.106
|
|
|
|
cgmp biosynthetic process
|
GO:0006182 |
12 |
0.105
|
|
|
|
regulation of endodermal cell fate specification
|
GO:0042663 |
1 |
0.104
|
|
|
|
synaptic vesicle recycling
|
GO:0036465 |
3 |
0.104
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.103
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.102
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.099
|
|
|
|
ureteric bud elongation
|
GO:0060677 |
2 |
0.098
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.096
|
|
|
|
cellular response to tumor necrosis factor
|
GO:0071356 |
63 |
0.094
|
|
|
|
positive regulation of multi organism process
|
GO:0043902 |
56 |
0.093
|
|
|
|
organ formation
|
GO:0048645 |
3 |
0.093
|
|
|
|
response to mechanical stimulus
|
GO:0009612 |
51 |
0.092
|
|
|
|
eye development
|
GO:0001654 |
42 |
0.092
|
|
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.090
|
|
|
|
response to alcohol
|
GO:0097305 |
64 |
0.089
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.089
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.089
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.088
|
|
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.086
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
124 |
0.085
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
111 |
0.085
|
|
|
|
response to hexose
|
GO:0009746 |
20 |
0.083
|
|
|
|
secretion by lung epithelial cell involved in lung growth
|
GO:0061033 |
2 |
0.082
|
|
|
|
cell proliferation in forebrain
|
GO:0021846 |
1 |
0.082
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
205 |
0.082
|
|
|
|
response to carbohydrate
|
GO:0009743 |
21 |
0.080
|
|
|
|
tangential migration from the subventricular zone to the olfactory bulb
|
GO:0022028 |
3 |
0.078
|
|
|
|
regulation of gtpase activity
|
GO:0043087 |
180 |
0.078
|
|
|
|
response to temperature stimulus
|
GO:0009266 |
22 |
0.077
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.076
|
|
|
|
mesodermal cell fate commitment
|
GO:0001710 |
2 |
0.076
|
|
|
|
camera type eye development
|
GO:0043010 |
25 |
0.075
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.074
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.074
|
|
|
|
response to peptide hormone
|
GO:0043434 |
61 |
0.074
|
|
|
|
response to glucocorticoid
|
GO:0051384 |
13 |
0.073
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.072
|
|
|
|
middle ear morphogenesis
|
GO:0042474 |
1 |
0.072
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.070
|
|
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.070
|
|
|
|
regulation of cardiac muscle cell proliferation
|
GO:0060043 |
4 |
0.070
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
166 |
0.070
|
|
|
|
response to heat
|
GO:0009408 |
21 |
0.069
|
|
|
|
regulation of sensory perception of pain
|
GO:0051930 |
3 |
0.067
|
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
4 |
0.067
|
|
|
|
steroid metabolic process
|
GO:0008202 |
94 |
0.067
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
3 |
0.066
|
|
|
|
cranial nerve development
|
GO:0021545 |
4 |
0.066
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
4 |
0.065
|
|
|
|
signal release
|
GO:0023061 |
70 |
0.064
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.064
|
|
|
|
regulation of axon extension involved in axon guidance
|
GO:0048841 |
2 |
0.064
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.063
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
97 |
0.063
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.062
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.062
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.062
|
|
|
|
forebrain neuron development
|
GO:0021884 |
2 |
0.061
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
3 |
0.061
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.060
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.060
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
1 |
0.059
|
|
|
|
regulation of branching involved in salivary gland morphogenesis by mesenchymal epithelial signaling
|
GO:0060665 |
1 |
0.059
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.059
|
|
|
|
regulation of axon guidance
|
GO:1902667 |
3 |
0.058
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
3 |
0.057
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.057
|
|
|
|
cerebral cortex tangential migration using cell cell interactions
|
GO:0021823 |
2 |
0.057
|
|
|
|
regulation of heart growth
|
GO:0060420 |
4 |
0.056
|
|
|
|
response to lipoprotein particle
|
GO:0055094 |
5 |
0.056
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.055
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.055
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.054
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
107 |
0.054
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.053
|
|
|
|
response to peptide
|
GO:1901652 |
65 |
0.053
|
|
|
|
response to ethanol
|
GO:0045471 |
11 |
0.053
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.051
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.050
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.050
|
|
|
|
branching involved in salivary gland morphogenesis
|
GO:0060445 |
1 |
0.050
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
166 |
0.050
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.049
|
|
|
|
response to fructose
|
GO:0009750 |
1 |
0.048
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.048
|
|
|
|
tissue regeneration
|
GO:0042246 |
3 |
0.048
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
239 |
0.047
|
|
|
|
positive regulation of keratinocyte migration
|
GO:0051549 |
4 |
0.047
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.046
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.046
|
|
|
|
system process
|
GO:0003008 |
349 |
0.046
|
|
|
|
cranial nerve formation
|
GO:0021603 |
1 |
0.046
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.046
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.045
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.045
|
|
|
|
hair cell differentiation
|
GO:0035315 |
2 |
0.045
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.045
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.044
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
4 |
0.044
|
|
|
|
lung growth
|
GO:0060437 |
2 |
0.043
|
|
|
|
post embryonic organ development
|
GO:0048569 |
1 |
0.043
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.043
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.043
|
|
|
|
cellular cation homeostasis
|
GO:0030003 |
163 |
0.042
|
|
|
|
regulation of metalloenzyme activity
|
GO:0048552 |
3 |
0.041
|
|
|
|
lung alveolus development
|
GO:0048286 |
4 |
0.041
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.041
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.041
|
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.041
|
|
|
|
endocytosis
|
GO:0006897 |
159 |
0.041
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.041
|
|
|
|
sensory perception of sound
|
GO:0007605 |
37 |
0.040
|
|
|
|
chondroblast differentiation
|
GO:0060591 |
2 |
0.040
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
181 |
0.040
|
|
|
|
glial cell migration
|
GO:0008347 |
4 |
0.040
|
|
|
|
regulation of sensory perception
|
GO:0051931 |
3 |
0.040
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.039
|
|
|
|
plasma membrane organization
|
GO:0007009 |
115 |
0.039
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.039
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.039
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
3 |
0.039
|
|
|
|
nerve development
|
GO:0021675 |
4 |
0.039
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.038
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.038
|
|
|
|
negative regulation of fibroblast migration
|
GO:0010764 |
3 |
0.038
|
|
|
|
endomembrane system organization
|
GO:0010256 |
196 |
0.038
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.038
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.038
|
|
|
|
epithelial tube branching involved in lung morphogenesis
|
GO:0060441 |
4 |
0.038
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.038
|
|
|
|
response to lead ion
|
GO:0010288 |
1 |
0.037
|
|
|
|
ectodermal placode development
|
GO:0071696 |
1 |
0.036
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.036
|
|
|
|
neuronal stem cell division
|
GO:0036445 |
1 |
0.036
|
|
|
|
spermatid differentiation
|
GO:0048515 |
4 |
0.035
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.035
|
|
|
|
gtp catabolic process
|
GO:0006184 |
237 |
0.035
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
85 |
0.035
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.035
|
|
|
|
killing of cells of other organism
|
GO:0031640 |
7 |
0.034
|
|
|
|
female pregnancy
|
GO:0007565 |
17 |
0.034
|
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
39 |
0.034
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.034
|
|
|
|
taxis
|
GO:0042330 |
157 |
0.034
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.034
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
104 |
0.033
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
185 |
0.032
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.032
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.032
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.032
|
|
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.032
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.032
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.032
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.032
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.032
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.031
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
15 |
0.031
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.031
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
51 |
0.031
|
|
|
|
regulation of cell cycle arrest
|
GO:0071156 |
36 |
0.031
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
4 |
0.031
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.031
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.031
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.031
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.030
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.030
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.030
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.030
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
4 |
0.030
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.029
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
24 |
0.029
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
207 |
0.029
|
|
|
|
limbic system development
|
GO:0021761 |
3 |
0.029
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.029
|
|
|
|
memory
|
GO:0007613 |
3 |
0.029
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.029
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
180 |
0.029
|
|
|
|
olfactory bulb interneuron differentiation
|
GO:0021889 |
2 |
0.029
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
3 |
0.029
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
180 |
0.029
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.029
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
39 |
0.028
|
|
|
|
pituitary gland development
|
GO:0021983 |
2 |
0.028
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.028
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.028
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
46 |
0.028
|
|
|
|
neuroblast division
|
GO:0055057 |
1 |
0.028
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
71 |
0.027
|
|
|
|
hindbrain development
|
GO:0030902 |
3 |
0.027
|
|
|
|
bile acid metabolic process
|
GO:0008206 |
14 |
0.027
|
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.027
|
|
|
|
regulation of urothelial cell proliferation
|
GO:0050675 |
1 |
0.027
|
|
|
|
mammary gland specification
|
GO:0060594 |
1 |
0.027
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
128 |
0.027
|
|
|
|
somatic stem cell division
|
GO:0048103 |
1 |
0.027
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.027
|
|
|
|
lung saccule development
|
GO:0060430 |
2 |
0.026
|
|
|
|
cell junction organization
|
GO:0034330 |
79 |
0.026
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.026
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.026
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
185 |
0.026
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.026
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.026
|
|
|
|
regulation of keratinocyte migration
|
GO:0051547 |
4 |
0.026
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
158 |
0.026
|
|
|
|
anterior posterior axis specification embryo
|
GO:0008595 |
2 |
0.026
|
|
|
|
response to bacterium
|
GO:0009617 |
144 |
0.025
|
|
|
|
cation homeostasis
|
GO:0055080 |
189 |
0.025
|
|
|
|
epithelial cell proliferation involved in lung morphogenesis
|
GO:0060502 |
3 |
0.025
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.025
|
|
|
|
branch elongation involved in ureteric bud branching
|
GO:0060681 |
2 |
0.025
|
|
|
|
protein lipid complex subunit organization
|
GO:0071825 |
24 |
0.025
|
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
4 |
0.025
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.025
|
|
|
|
neuroendocrine cell differentiation
|
GO:0061101 |
2 |
0.025
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
169 |
0.025
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.025
|
|
|
|
negative regulation of axonogenesis
|
GO:0050771 |
4 |
0.024
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.024
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.024
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.024
|
|
|
|
positive regulation of heart growth
|
GO:0060421 |
2 |
0.024
|
|
|
|
positive regulation of organ growth
|
GO:0046622 |
2 |
0.024
|
|
|
|
negative regulation of endodermal cell differentiation
|
GO:1903225 |
2 |
0.024
|
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.024
|
|
|
|
cell junction maintenance
|
GO:0034331 |
4 |
0.024
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.024
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.024
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
177 |
0.024
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.024
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
97 |
0.024
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
187 |
0.024
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.024
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.024
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
67 |
0.023
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
176 |
0.023
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.023
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
190 |
0.023
|
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.023
|
|
|
|
aging
|
GO:0007568 |
66 |
0.023
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.023
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
3 |
0.023
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.023
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.023
|
|
|
|
toxin transport
|
GO:1901998 |
4 |
0.023
|
|
|
|
regulation of hair follicle cell proliferation
|
GO:0071336 |
1 |
0.023
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
179 |
0.023
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
188 |
0.023
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.023
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
147 |
0.023
|
|
|
|
positive regulation of immune response
|
GO:0050778 |
159 |
0.023
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
84 |
0.022
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
82 |
0.022
|
|
|
|
growth
|
GO:0040007 |
202 |
0.022
|
|
|
|
sensory organ development
|
GO:0007423 |
52 |
0.022
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.022
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.022
|
|
|
|
stem cell division
|
GO:0017145 |
2 |
0.022
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
117 |
0.022
|
|
|
|
organelle assembly
|
GO:0070925 |
176 |
0.022
|
|
|
|
regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:2000794 |
2 |
0.022
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.022
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
2 |
0.021
|
|
|
|
mesenchymal epithelial cell signaling
|
GO:0060638 |
1 |
0.021
|
|
|
|
spermatid development
|
GO:0007286 |
4 |
0.021
|
|
|
|
sensory perception
|
GO:0007600 |
103 |
0.021
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.021
|
|
|
|
positive regulation of hair follicle cell proliferation
|
GO:0071338 |
1 |
0.021
|
|
|
|
regulation of neuronal synaptic plasticity
|
GO:0048168 |
1 |
0.021
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.021
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.021
|
|
|
|
endodermal cell fate commitment
|
GO:0001711 |
4 |
0.021
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
102 |
0.021
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
186 |
0.021
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.021
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
2 |
0.021
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.020
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.020
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.020
|
|
|
|
positive regulation of cardiac muscle tissue growth
|
GO:0055023 |
2 |
0.020
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.020
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.020
|
|
|
|
regulation of endodermal cell differentiation
|
GO:1903224 |
3 |
0.020
|
|